Sarkar Shubho R, Kotanko Peter, Heymsfeld Steven B, Levin Nathan W
Weill Cornell Medical Center, New York-Presbyterian Hospital, New York, New York, USA.
Semin Dial. 2007 Sep-Oct;20(5):379-82. doi: 10.1111/j.1525-139X.2007.00322.x.
Since the demonstration that dialysis patients with lower body weight have a higher mortality than larger patients, there has been much interest in determining possible mechanisms and any possible relationships to the dialysis dose. Arguments have been made against using Kt/V(urea) as the basis for dialysis prescription. Efforts have been made to determine a parameter of dialysis delivery independent of body size. An emerging area of intense research interest has explored the body composition determinants of resting metabolic rate. Based on the knowledge of in vitro organ tissue energy production, newer high-resolution imaging methods have been applied as a means of establishing the sources of resting energy production in chronic kidney disease (CKD) patients. However, the linkages between resting energy expenditure (REE), body composition, and survival have not received much attention despite various studies exploring the effect of renal dysfunction and of the hemodialysis process on REE. We explore possible mechanisms leading to a higher mortality in smaller (lower body mass index) patients. The hypothesis of Morton and Singer is discussed. We have hypothesized that delivery of dialysis based on visceral organ volume (V(organ)), which could be the appropriate representation of uremic toxin generation, would be more logical than the current practice. This retains the concept of Kt/V but suggests that instead of the total V, a component related to major metabolic activity might represent the volume of interest. As per our hypothesis, smaller dialysis patients would need relatively a higher dialysis dose delivery, as expressed by current Kt/V, in order to achieve the same level of clearance of uremic toxins as in larger patients.
自从有证据表明体重较低的透析患者比体型较大的患者死亡率更高以来,人们对确定可能的机制以及与透析剂量的任何可能关系产生了浓厚兴趣。有人反对将尿素清除率(Kt/V)作为透析处方的依据。人们努力确定一个与体型无关的透析剂量参数。一个新兴的研究热点领域探索了静息代谢率的身体成分决定因素。基于体外器官组织能量产生的知识,更新的高分辨率成像方法已被应用,作为确定慢性肾脏病(CKD)患者静息能量产生来源的一种手段。然而,尽管有各种研究探讨了肾功能不全和血液透析过程对静息能量消耗(REE)的影响,但REE、身体成分和生存率之间的联系并未受到太多关注。我们探讨了导致体型较小(体重指数较低)患者死亡率较高的可能机制。讨论了莫顿和辛格的假设。我们假设基于内脏器官体积(V(器官))进行透析,这可能是尿毒症毒素产生的合适代表,比目前的做法更合理。这保留了Kt/V的概念,但表明与主要代谢活动相关的一个组成部分而非总体积,可能代表感兴趣的体积。根据我们的假设,体型较小的透析患者需要相对较高的透析剂量(以目前的Kt/V表示),以便达到与体型较大患者相同水平的尿毒症毒素清除率。